BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23072894)

  • 1. Evaluation of an attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis.
    Rudoler N; Baneth G; Eyal O; van Straten M; Harrus S
    Vaccine; 2012 Dec; 31(1):226-33. PubMed ID: 23072894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the acute phase protein and antioxidant responses in dogs vaccinated against canine monocytic ehrlichiosis and naive-challenged dogs.
    Rudoler N; Harrus S; Martinez-Subiela S; Tvarijonaviciute A; van Straten M; Cerón JJ; Baneth G
    Parasit Vectors; 2015 Mar; 8():175. PubMed ID: 25888870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of 10% imidacloprid/50% permethrin to prevent Ehrlichia canis exposure in dogs under natural conditions.
    Otranto D; Paradies P; Testini G; Latrofa MS; Weigl S; Cantacessi C; Mencke N; de Caprariis D; Parisi A; Capelli G; Stanneck D
    Vet Parasitol; 2008 May; 153(3-4):320-8. PubMed ID: 18359166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine gene expression by peripheral blood leukocytes in dogs experimentally infected with a new virulent strain of Ehrlichia canis.
    Unver A; Huang H; Rikihisa Y
    Ann N Y Acad Sci; 2006 Oct; 1078():482-6. PubMed ID: 17114759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis.
    Dawson JE; Ewing SA
    Am J Vet Res; 1992 Aug; 53(8):1322-7. PubMed ID: 1510307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of Ehrlichia canis by multiple passages in two different cultures.
    Or M; Samish M; Waner T; Harrus S
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 2():74-5. PubMed ID: 19438628
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokine responses in dogs infected with Ehrlichia canis Oklahoma strain.
    Tajima T; Rikihisa Y
    Ann N Y Acad Sci; 2005 Dec; 1063():429-32. PubMed ID: 16481554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum acute phase proteins as clinical phase indicators and outcome predictors in naturally occurring canine monocytic ehrlichiosis.
    Mylonakis ME; Ceron JJ; Leontides L; Siarkou VI; Martinez S; Tvarijonaviciute A; Koutinas AF; Harrus S
    J Vet Intern Med; 2011; 25(4):811-7. PubMed ID: 21564293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of lymphocyte populations in dogs naturally infected by Ehrlichia canis with and without clinical signs.
    Villaescusa A; Tesouro MA; García-Sancho M; Ayllón T; Rodríguez-Franco F; Sainz A
    Ticks Tick Borne Dis; 2012 Dec; 3(5-6):279-82. PubMed ID: 23168046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular signs of canine monocytic ehrlichiosis: a retrospective study in dogs from Barcelona, Spain.
    Leiva M; Naranjo C; Peña MT
    Vet Ophthalmol; 2005; 8(6):387-93. PubMed ID: 16359361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of rifampicin in the treatment of experimental acute canine monocytic ehrlichiosis.
    Theodorou K; Mylonakis ME; Siarkou VI; Leontides L; Koutinas AF; Koutinas CK; Kritsepi-Konstantinou M; Batzias G; Flouraki E; Eyal O; Kontos V; Harrus S
    J Antimicrob Chemother; 2013 Jul; 68(7):1619-26. PubMed ID: 23475646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Entry-Triggering Protein of
    Budachetri K; Teymournejad O; Lin M; Yan Q; Mestres-Villanueva M; Brock GN; Rikihisa Y
    mBio; 2020 Jul; 11(4):. PubMed ID: 32723916
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental acute canine monocytic ehrlichiosis: clinicopathological and immunopathological findings.
    de Castro MB; Machado RZ; de Aquino LP; Alessi AC; Costa MT
    Vet Parasitol; 2004 Jan; 119(1):73-86. PubMed ID: 15036578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective clinical and molecular analysis of conditioned laboratory dogs (Canis familiaris) with serologic reactions to Ehrlichia canis, Borrelia burgdorferi, and Rickettsia rickettsii.
    Scorpio DG; Wachtman LM; Tunin RS; Barat NC; Garyu JW; Dumler JS
    J Am Assoc Lab Anim Sci; 2008 Sep; 47(5):23-8. PubMed ID: 18947166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of peripheral blood lymphocyte subsets in family-owned dogs naturally infected by Ehrlichia canis.
    Villaescusa A; Tesouro MA; García-Sancho M; Ayllón T; Rodríguez-Franco F; Sainz A
    Comp Immunol Microbiol Infect Dis; 2012 Jul; 35(4):391-6. PubMed ID: 22521727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of canine monocytotropic ehrlichiosis (Ehrlichia canis): an overview.
    Harrus S; Waner T
    Vet J; 2011 Mar; 187(3):292-6. PubMed ID: 20226700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection and characterization of Ehrlichia canis from dogs in Turkey.
    Unver A; Rikihisa Y; Borku K; Ozkanlar Y; Hanedan B
    Berl Munch Tierarztl Wochenschr; 2005; 118(7-8):300-4. PubMed ID: 16048040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid cytology in experimental acute canine monocytic ehrlichiosis (Ehrlichia canis).
    Theodorou K; Leontides L; Siarkou VI; Petanides T; Tsafas K; Harrus S; Mylonakis ME
    Vet Microbiol; 2015 May; 177(1-2):224-7. PubMed ID: 25770893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ehrlichial infection in Cameroonian canines by Ehrlichia canis and Ehrlichia ewingii.
    Ndip LM; Ndip RN; Esemu SN; Dickmu VL; Fokam EB; Walker DH; McBride JW
    Vet Microbiol; 2005 Nov; 111(1-2):59-66. PubMed ID: 16181750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Ehrlichia canis infection in the dog does not cause immunosuppression.
    Hess PR; English RV; Hegarty BC; Brown GD; Breitschwerdt EB
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):117-25. PubMed ID: 16169601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.